Literature DB >> 11120830

Factors controlling the trafficking and processing of a leader-derived peptide presented by Qa-1.

A Bai1, C J Aldrich, J Forman.   

Abstract

Many leader-derived peptides require TAP for presentation by class I molecules. This TAP dependence can either be ascribed to the inability of proteases resident in the endoplasmic reticulum (ER) to trim leader peptide precursors into the appropriate epitope or the failure of a portion of the leader segment to gain access to the lumen of the ER. Using the Qa-1 binding epitope, Qdm derived from a class Ia leader as a model, we show that many cell types lack ER protease activity to trim this peptide at its C terminus. However, both T1 and T2 cells contain appropriate protease activity to process the full length D(d) leader (DL) when introduced into the ER lumen. Nevertheless, both T1 cells treated with the TAP inhibitor ICP47 and TAP(-) T2 cells fail to present this epitope from either the intact D(d) molecule or a minigene encoding the DL. This indicates that the portion of the leader containing Qdm does not gain access to the ER. However, changing the Arg at P7 of the DL to a Cys can alter its trafficking and allows for TAP-independent presentation of the Qdm epitope.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120830     DOI: 10.4049/jimmunol.165.12.7025

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Isoforms of the nonclassical class I MHC antigen H2-Q5 are enriched in brain and encode Qdm peptide.

Authors:  Nora E Renthal; Paula A Guidry; Sharmila Shanmuganad; William Renthal; Iwona Stroynowski
Journal:  Immunogenetics       Date:  2010-10-22       Impact factor: 2.846

2.  The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.

Authors:  Victor H Engelhard
Journal:  Int J Mass Spectrom       Date:  2007-01-01       Impact factor: 1.986

3.  In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules.

Authors:  Jingbo Yan; Vrajesh V Parekh; Yanice Mendez-Fernandez; Danyvid Olivares-Villagómez; Srdjan Dragovic; Timothy Hill; Derry C Roopenian; Sebastian Joyce; Luc Van Kaer
Journal:  J Exp Med       Date:  2006-02-27       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.